Introduction of Multisite Evaluation Study on Analytical Methods for Non-Clinical Safety Assessment of Human-derived Regenerative Medical Products (MEASURE), a Japanese Experimental Consortium for Standardization of Tumorigenicity Testing Methods
-
- BANDO Hiroto
- Takeda Pharmaceutical Company Limited
-
- YAMAMOTO Keiji
- Takeda Pharmaceutical Company Limited
-
- NARAOKA Hitoshi
- Astellas Pharma Inc.
-
- MIYOSHI Sousuke
- Astellas Pharma Inc.
-
- WATANABE Takeshi
- Takeda Pharmaceutical Company Limited
-
- AZUMA Akihiko
- FUJIFILM Corporation
-
- BANDO Kiyoko
- Sumitomo Dainippon Pharma Co., Ltd.
-
- SUZUKI Mutsumi
- Kyowa Hakko Kirin Co., Ltd
-
- NISHIDA Hitoshi
- TERUMO CORPORATION
-
- KOJITANI Takatoshi
- Sumitomo Dainippon Pharma Co., Ltd.
-
- TANAKA Naoko
- TERUMO CORPORATION
-
- KAMIYAMA Yoshiteru
- Astellas Pharma Inc.
-
- NISHIGAKI Fusako
- Astellas Pharma Inc.
-
- MURAOKA Hitomi
- National Institute of Health Science
-
- YASUDA Satoshi
- National Institute of Health Science
-
- SATO Yoji
- National Institute of Health Science
Bibliographic Information
- Other Title
-
- 再生医療製品等の造腫瘍性試験のバリデーションのための産官連携多施設共同研究「MEASURE」の取り組み
Abstract
<p>[in Japanese] </p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 45.1 (0), W4-3-, 2018
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390564238009749376
-
- NII Article ID
- 130007431913
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed